BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 8599974)

  • 1. Erythroid AP-1/NF-E2 elements vary in their response to NF-E2.
    Walters M; Andrews NC; Magis W; Martin DI
    Exp Hematol; 1996 Feb; 24(3):445-52. PubMed ID: 8599974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of chromatin structure on bleomycin-DNA interactions at base pair resolution in the human beta-globin gene cluster.
    Cairns MJ; Murray V
    Biochemistry; 1996 Jul; 35(26):8753-60. PubMed ID: 8679639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Jun inhibits NF-E2 transcriptional activity in association with p18/maf in Friend erythroleukemia cells.
    Francastel C; Augery-Bourget Y; Prenant M; Walters M; Martin DI; Robert-Lézénès J
    Oncogene; 1997 Feb; 14(7):873-7. PubMed ID: 9047395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural analysis and mapping of DNase I hypersensitivity of HS5 of the beta-globin locus control region.
    Li Q; Zhang M; Duan Z; Stamatoyannopoulos G
    Genomics; 1999 Oct; 61(2):183-93. PubMed ID: 10534403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythroid transcription factor NF-E2 is a haematopoietic-specific basic-leucine zipper protein.
    Andrews NC; Erdjument-Bromage H; Davidson MB; Tempst P; Orkin SH
    Nature; 1993 Apr; 362(6422):722-8. PubMed ID: 8469283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse microcytic anaemia caused by a defect in the gene encoding the globin enhancer-binding protein NF-E2.
    Peters LL; Andrews NC; Eicher EM; Davidson MB; Orkin SH; Lux SE
    Nature; 1993 Apr; 362(6422):768-70. PubMed ID: 8469289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p45 NF-E2 regulates expression of thromboxane synthase in megakaryocytes.
    Deveaux S; Cohen-Kaminsky S; Shivdasani RA; Andrews NC; Filipe A; Kuzniak I; Orkin SH; Roméo PH; Mignotte V
    EMBO J; 1997 Sep; 16(18):5654-61. PubMed ID: 9312024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A major role for the TATA box in recruitment of chromatin modifying complexes to a globin gene promoter.
    Gui CY; Dean A
    Proc Natl Acad Sci U S A; 2003 Jun; 100(12):7009-14. PubMed ID: 12773626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
    Suhasini M; Boss GR; Pascual FE; Pilz RB
    Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heme-dependent up-regulation of the alpha-globin gene expression by transcriptional repressor Bach1 in erythroid cells.
    Tahara T; Sun J; Igarashi K; Taketani S
    Biochem Biophys Res Commun; 2004 Nov; 324(1):77-85. PubMed ID: 15464985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinction between AP1 and NF-E2 factor-binding at specific chromatin regions in mammalian cells.
    Daftari P; Gavva NR; Shen CK
    Oncogene; 1999 Sep; 18(39):5482-6. PubMed ID: 10498903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of beta-major globin gene transcription is associated with recruitment of NF-E2 to the beta-globin LCR and gene promoter.
    Sawado T; Igarashi K; Groudine M
    Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10226-31. PubMed ID: 11517325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythroid regulatory elements.
    Raich N; Romeo PH
    Stem Cells; 1993 Mar; 11(2):95-104. PubMed ID: 8096156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted remodeling of human beta-globin promoter chromatin structure produces increased expression and decreased silencing.
    Iler N; Goodwin AJ; McInerney J; Nemeth MJ; Pomerantz O; Layon ME; Lowrey CH
    Blood Cells Mol Dis; 1999 Feb; 25(1):47-60. PubMed ID: 10349513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sumoylation of p45/NF-E2: nuclear positioning and transcriptional activation of the mammalian beta-like globin gene locus.
    Shyu YC; Lee TL; Ting CY; Wen SC; Hsieh LJ; Li YC; Hwang JL; Lin CC; Shen CK
    Mol Cell Biol; 2005 Dec; 25(23):10365-78. PubMed ID: 16287851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transactivation activity of Maf nuclear oncoprotein is modulated by Jun, Fos and small Maf proteins.
    Kataoka K; Noda M; Nishizawa M
    Oncogene; 1996 Jan; 12(1):53-62. PubMed ID: 8552399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA-protein interactions in the proximal zeta-globin promoter: identification of novel CCACCC- and CCAAT-binding proteins.
    Sabath DE; Koehler KM; Yang WQ; Phan V; Wilson J
    Blood Cells Mol Dis; 1998 Jun; 24(2):183-98. PubMed ID: 9642099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region.
    Moi P; Chan K; Asunis I; Cao A; Kan YW
    Proc Natl Acad Sci U S A; 1994 Oct; 91(21):9926-30. PubMed ID: 7937919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human small Maf proteins form heterodimers with CNC family transcription factors and recognize the NF-E2 motif.
    Toki T; Itoh J; Kitazawa J; Arai K; Hatakeyama K; Akasaka J; Igarashi K; Nomura N; Yokoyama M; Yamamoto M; Ito E
    Oncogene; 1997 Apr; 14(16):1901-10. PubMed ID: 9150357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gamma-globin gene promoter elements required for interaction with globin enhancers.
    Langdon SD; Kaufman RE
    Blood; 1998 Jan; 91(1):309-18. PubMed ID: 9414299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.